Cerity Partners LLC Invests $303,000 in Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Cerity Partners LLC invested $303,000 in Option Care Health, acquiring 8,666 shares during the 1st quarter of the year.
• Analysts have set a consensus target price of $35.50 for Option Care Health, with seven analysts rating the stock as a "buy."
• Option Care Health reported a 16.3% year-over-year increase in revenue, totaling $1.33 billion, and beat earnings expectations with $0.40 EPS for the last quarter.

Cerity Partners LLC purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The firm purchased 8,666 shares of the company's stock, valued at approximately $303,000.

A number of other institutional investors have also modified their holdings of OPCH. Vanguard Group Inc. raised its position in shares of Option Care Health by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock valued at $448,118,000 after purchasing an additional 75,313 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock valued at $425,143,000 after purchasing an additional 8,400,208 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Option Care Health by 17.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after purchasing an additional 591,042 shares during the last quarter. Northern Trust Corp raised its position in shares of Option Care Health by 11.8% in the 4th quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock valued at $60,934,000 after purchasing an additional 278,158 shares during the last quarter. Finally, Norges Bank purchased a new position in shares of Option Care Health in the 4th quarter valued at approximately $60,219,000. 98.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

OPCH has been the subject of several research analyst reports. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research report on Thursday. JMP Securities set a $38.00 price target on shares of Option Care Health and gave the stock a "market outperform" rating in a research report on Thursday. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Finally, Barrington Research reissued an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Thursday, July 10th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, Option Care Health has an average rating of "Moderate Buy" and a consensus target price of $35.75.

Option Care Health Stock Performance

OPCH traded down $0.39 during trading on Thursday, reaching $30.25. 441,654 shares of the company's stock were exchanged, compared to its average volume of 1,852,568. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.54 and a quick ratio of 1.02. The stock has a market capitalization of $4.95 billion, a P/E ratio of 24.37, a price-to-earnings-growth ratio of 1.96 and a beta of 0.73. The company's fifty day simple moving average is $31.16 and its 200-day simple moving average is $31.95.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. The business's revenue was up 15.4% on a year-over-year basis. During the same quarter last year, the company earned $0.30 EPS. As a group, research analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.